Federal contract award
W15QKN21C0012
COVID-19 VACCINE PRODUCTION
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | W6QK ACC-PICA |
| NAICS | 325414 — Biological Product (except Diagnostic) Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $11.1B |
| Current contract value | $11.1B |
| Potential contract value / ceiling | $11.3B |
| Start date | Dec 22, 2020 |
| Current end date | Jun 30, 2023 |
| Potential end date | Jun 30, 2023 |
| Latest award activity | Mar 11, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 30 of 30 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Mar 11, 2025 | P00028 | $-30 | DEOBLIGATION IN SUPPORT OF CLOSEOUT. |
| Mar 11, 2025 | P00028 | $-30 | DEOBLIGATION IN SUPPORT OF CLOSEOUT. |
| Jun 28, 2023 | P00027 | $-33.8M | VMI TRANSFER |
| Apr 26, 2023 | P00026 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO UPDATE THE TYPE OF DOSES BEING DELIVERED. |
| Dec 27, 2022 | P00025 | $-10.0M | DEOBLIGATE 10M FROM CLIN 0050 TO SUPPORT INTERNATIONAL DONACTIONS |
| Oct 12, 2022 | P00024 | $0 | CHANGE GOVERNMENT TECHNICAL POC |
| Aug 11, 2022 | P00023 | $29.9M | THE PURPOSE OF THIS MODIFICATION IS TO UPDATE AGE GROUPS FOR DELIVERY OF DOSES AND ADD FUNDS FOR PREMIUM VARIANT DOSES. |
| Apr 29, 2022 | P00022 | $-1.9M | THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE FROM 30 APRIL 2022 TO 30 JUNE 2023. THIS MODIFICATION ALSO PROCESSES A RATIFICATION OF AN UNAUTHORIZED COMMITMENT. |
| Feb 18, 2022 | P00021 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO ADD CLAUSES THAT WERE OMITTED AT AWARD, UPDATE THE SOW, AND ADD GFP CLAUSES. |
| Jan 25, 2022 | P00020 | $0 | VACCINE DONATION |
| Nov 30, 2021 | P00019 | $0 | SWAP FUNDING ON CLIN 0054 TO 2 NEWLEY CREATED CLINS 0055 & 0056. |
| Nov 23, 2021 | P00018 | $80.4M | THE PURPOSE OF THIS MODIFICATION IS TO SWAP 19M DOSES OF ADULT PBS DOSES WITH 5M PEDS DOSES & 11M ADULT TRIS. ADDITIONAL UPDATE THE DELIVERY SCHEDULE. |
| Oct 22, 2021 | P00017 | $1.2B | DELEGATE CONTRACT ADMIN DCMA AND ADD GFP CLAUSES & ATTACHMENT TO CONTRACT. |
| Sep 24, 2021 | P00016 | $0 | THE PURPOSE OF THIS ACTION IS TO SWAP FUNDING FOR 22.5M DOSES OF VACCINE AND REQUIRED DILUENT. |
| Sep 20, 2021 | P00015 | $902.1M | THE PURPOSE OF THIS MODIFICATION IS TO ACCELERATE THE DELIVER SCHEDULE OF 22.5M DOSES OF ALREADY EXERCISED OPTIONS AND EXERCISE AN ADDITIONAL 50M DOSES WHILE CHANGING THE DELIVERED FORMULATION FROM RTU TO FROZEN FORMULATION. |
| Sep 8, 2021 | P00014 | $-41.0M | THE PURPOSE OF THIS MODIFICATION IS TO ACCELERATE THE DELIVER SCHEDULE OF 10M DOSES OF VACCINE. |
| Aug 27, 2021 | P00013 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO UPDATE APPENDIX 4 AND GOVT POC. |
| Aug 2, 2021 | P00012 | $0 | THIS MODIFICATION IS TO UPDATE ATTACHMENT 004 - APPENDIX 4 DONATION OF EXCESS PRODUCT. |
| Jul 31, 2021 | P00011 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO AUTHORIZED TO ROTATE A MINIMUM OF 9.1M DOSES AND UP TO 15M DOSES THAT THE USG HAS CURRENTLY REVIEWED AND APPROVED. |
| Jul 30, 2021 | P00010 | $0 | THIS MODIFICATION IS TO UPDATE APPENDIX 4 - DONATION OF EXCESS PRODUCT |
| Jul 21, 2021 | P00009 | $4.9B | THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE THE OPTION UNDER CLIN 0012 THROUGH 0020. ALL OTHER TERMS, AND CONDITIONS REMAIN IN FULL FORCE, AND EFFECT. |
| Jul 20, 2021 | P00008 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO RESTRUCTURE THE CLINS TO ADD OPTIONS FOR PEDIATRIC DOSES |
| Jul 16, 2021 | P00007 | $30.0M | ADD ADDITIONAL T&M CLIN FOR INTERNATIONAL SHIPPING FOR DONATION OF VACCINES. |
| Jul 9, 2021 | P00006 | $0 | UPDATE APPENDIX - 4 "DONATION OF EXCESS PRODUCT" |
| Jun 25, 2021 | P00005 | $0 | DONATION OF EXCESS PRODUCT LANGUAGE |
| Apr 16, 2021 | P00004 | $42.1M | THE PURPOSE OF THIS MODIFICATION IS TO ADD FUNDING TO ALLOW FOR DELIVERY OF 36 MILLION DOSES IN A SMALL PACKAGING CONFIGURATION |
| Apr 13, 2021 | P00003 | $0 | UPDATE ATTACHMENT 3 UPDATE (LDV SYRINGES). |
| Mar 1, 2021 | P00002 | $0 | UPDATE SHIP TO DODAAC FOR CLINS 1,2 & 4-35. |
| Feb 11, 2021 | P00001 | $2.0B | EXERCISE VACCINE AND DILUENT OPTIONS 1-4 FOR 100M DOSES AND ASSOCIATED DILUENT. |
| Dec 22, 2020 | 0 | $2.0B | COVID-19 VACCINE PRODUCTION |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.